featured
-
News
JUST RELEASED | 5th Edition of TIF’s Guidelines for the Management of Transfusion Dependent β-Thalassaemia
This edition stands as a seminal resource that provides critical guidance and recommendations to healthcare professionals across various specialties, researchers and all stakeholders involved in the care of individuals affected…
Read More » -
News
TIF AI KNOWLEDGE BOT | Your Go-To Source for Thalassaemia Information
In the world of healthcare, staying informed is key. That is why the TIF AI Knowledge Bot is here to revolutionize how you access thalassaemia information. Designed with patients, caregivers,…
Read More » -
News
EDUCATIONAL WEBINAR ON HEART COMPLICATIONS IN HAEMOGLOBINOPATHIES | 30 January 2025
📌 Webinar Title: Management of Thalassaemia: Heart Complications in Haemoglobinopathies 📌 Date & Time: Thursday, 30 January 2025, 13:00 New York / 14:00 Rio de Janeiro / 20:00 Athens …
Read More » -
News
HEALTH TECHNOLOGY ASSESSMENT | EU Implements New Rules to Offer Quicker Access to Advanced Medicines
The new rules establish an EU-wide framework for assessing health technologies by promoting collaboration and coordination among EU Member States. The goal is to help national authorities make more timely…
Read More » -
News
TIF READINESS ASSESSMENT TOOL | Is Your Country Ready for Advanced Thalassaemia Therapies?
In an era where medical advancements are progressing at an unprecedented rate, ensuring that these breakthroughs are accessible and appropriately integrated into national healthcare systems is a paramount challenge. This…
Read More » -
News
WEBINAR | New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions
📌 Webinar Title: New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions 📌 Date & Time: Tuesday, 21 January 2025 | 14:30-16:00 Athens Time, 19:30-21:00 Kuala Lumpur Time Webinar…
Read More » -
News
POSITION PAPER | The Views of TIF on Advanced Therapy Medicinal Products (ATMPs)
The Thalassaemia International Federation (TIF) is pleased to share its newly published Position Paper, titled “Advanced Therapy Medicinal Products (ATMPs).” This comprehensive document delves into the challenges eligible patients face…
Read More » -
News
INFOGRAPHICS | Mapping Blood Use in Patients with Thalassaemia Across the EU
Have You Ever Wondered How Much Blood is Consumed by Patients with Thalassaemia in EU Countries? To answer this question, the Thalassaemia International Federation (TIF) collected data from 15 EU…
Read More » -
News
EXCLUSIVE WEBINAR | Iron Load and the Importance of Reliable Monitoring in Haemoglobin Disorders
📌 Webinar Title: Iron Load and the Importance of Reliable Monitoring in Haemoglobin Disorders – The Transfusion Dependent Thalassaemia (TDT) Perspective 📌 Date & Time: 5 December 2024 / 13:30…
Read More » -
News
EDUCATIONAL WEBINAR FOR PATIENTS ON IRON OVERLOAD AND MONITORING | 21 November 2024
📌 Webinar Title: Webinar for Patients on Iron Overload and Iron Monitoring 📌 Date & Time: Thursday, November 21, 13:00 New York / 14:00 Rio de Janeiro This webinar…
Read More »